Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

53.29 -0.25 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
More Trouble Ahead For Bulls? Prepare For The Busy Upcoming Week With Mando Trading!
Jackson Hole Week comes to a close with a pretty ugly weekly candle. With DXY still strong, it's pretty hard for me to be bullish on the higher time frame right now. That weekly volume imbalance just... 
Via Benzinga
Ross Stores, Vertex Pharmaceuticals And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca
China’s drug distributors are in the hunt to acquire Poland’s Neuca, a company with a 32% market share of Poland’s pharmaceutical distribution business. The consortium of China’s drug distributors may... 
Via Talk Markets
Is Alexandria Real Estate Equities a Buy?
Great company, attractive valuation, lousy sector. 
Via The Motley Fool
Moderna Unusual Options Activity
Via Benzinga
Check Out What Whales Are Doing With MRNA
Via Benzinga
Moderna Inc. (NASDAQ: MRNA) Highlighted for Surprising Price Action
Via Investor Brand Network
MRNA Stock Alert: Why Is Moderna Up 7% Today?
Investors in Moderna (MRNA) stock have received a boost today from reports that a late summer Covid wave could be on the horizon. 
Via InvestorPlace
Exposures COVID-19
Market Rally Attempt Suffers Big Reversal Amid Nvidia Earnings, Powell Speech: Weekly Review
A rally attempt gained momentum, until Thursday's ugly reversal. 
Via Investor's Business Daily
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader. 
Via InvestorPlace
Novavax (NVAX) Stock Is Getting Ready to Rally Again
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot. 
Via InvestorPlace
Exposures COVID-19
Tuesday Talk: Monday Rebound
On Monday, the market rallied to rebound higher after a tough week of sideways and downward action. It remains to be seen if the rebound will be sustainable. 
Via Talk Markets
Moderna Inc. (NASDAQ: MRNA) is a Leading Gainer in 8/17 Morning Trading
Via Investor Brand Network
Nvidia, Zoom, Moderna, Baidu, Tesla: Why These Five Stocks Are Drawing Investors' Attention Today
Via Benzinga
Why Moderna, BioNTech SE, and Novavax Surged Today
The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign. 
Via The Motley Fool
Exposures COVID-19
S&P 500: Cybersecurity Giant Soars On Earnings; Tesla, Nvidia Are Big Winners
Palo Alto surged on earnings. Tesla and NVDA were big winners too. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Crude Oil Falls; Nikola Shares Plummet
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded down 0.16% to 34,446.91 while the NASDAQ rose 1.52% to 13,492.73. The S&P... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Dow Tumbles Over 100 Points; Timber Pharmaceuticals Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.40% to 34,362.93 while the NASDAQ rose 0.78% to 13,394.60. The S&P 500,... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33. 
Via Benzinga
Moderna Surges On A Second, Unexpected Shot At The Cancer Vaccine Market
The company inked a new deal on Monday to test a new regimen using a second cancer vaccine. 
Via Investor's Business Daily
Moderna Teams Up With Chinese Biotech To Assess Cell-Based Therapy And Cancer Vaccine Combo
A Chinese biotech, CARsgen Therapeutics and Moderna Inc (NASDAQ: MRNA) have collaborated 
Via Benzinga
Moderna, BioNTech And Other Big Stocks Moving Higher On Monday
U.S. stocks traded mixed, with the Dow Jones falling around 150 points on Monday. Here are some big stocks recording gains in today’s session. Genelux Corporation (NASDAQ: GNLX) gained 19.2% to $28.58.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Will The Bears Deliver The Knockout? Prepare For The Upcoming Week With Mando Trading!
$SPY (ARCA: SPY) Have lows been put in or is there more to go? Slow start to the week In terms of data, but a big finish with Jackson Hole starting Thursday and Powell on Friday. This event crushed the... 
Via Benzinga
SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories
Benzinga 
Via Benzinga
Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance
The companies are hoping to launch their updated Covid shots in September. 
Via Investor's Business Daily
Exposures COVID-19
2 Biotech Stocks That Could Make You Richer
Neither is performing particularly well this year compared to the broader market, but don't let that chase you away. 
Via The Motley Fool
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies
Moderna Inc (NASDAQ: MRNA) announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies... 
Via Benzinga
Exposures COVID-19
Moderna Clinical Trial Data Confirm Its Updated COVID-19 Vaccine Generates Robust Immune Response in Humans Against Widely Circulating Variants
Via ACCESSWIRE
Cheaper Alternatives of Weight-Loss Drugs? Chinese Pharma Companies Are Working On a Local Version
Chinese pharma firms are reportedly working on producing local equivalents of advanced weight-loss medications, challenging Western pharmaceutical giants in a  
Via Benzinga
Your Mid-August Market Update: Selling And Scanning
Stock indexes slid 1% today with bonds closing weaker, down at 2023 lows as interest rates traded up to highs in 2023. 
Via Talk Markets
Topics Bonds
Exposures Debt Markets
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.